InsiderTrades

Form 4 for CPRT Copart

Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-15 · accession 0001628280-26-002311 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-01-16 2026-01-15 CPRT Liaw Jeffrey CEO M - OptEx $8.49 +49.8K 81.1K +159% +$422.8K
DM 2026-01-16 2026-01-15 CPRT Liaw Jeffrey CEO S - Sale+OE $40.17 -25.1K 56.0K -31% -$1.01M
DM 2026-01-16 2026-01-15 CPRT Liaw Jeffrey CEO M - OptEx $0.00 -49.8K 10.7K -82% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-15 M A 809 $6.78 79,830 D — —
2 Common Common Stock 2026-01-15 M A 43,166 $8.70 79,021 D — —
3 Common Common Stock 2026-01-15 M A 4,523 $6.78 35,855 D — —
4 Common Common Stock 2026-01-15 S D 2,444 $40.17 78,663 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.94 to $40.66, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. (F2) The reported sale of 2,444 shares shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
5 Common Common Stock 2026-01-15 S D 22,693 $40.17 55,970 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.47, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. (F4) The reported sale of 22,693 shares occurred automatically pursuant to a 10b-1 plan adopted by the reporting person on April 15, 2025.
6 Common Common Stock 2026-01-15 M A 1,277 $8.70 81,107 D — —
7 Derivative Employee Stock Option (right to buy) 2026-01-15 M D 4,523 $0.00 11,477 D $6.78 · — to 2026-10-10 4,523 Common Stock (F5) Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the the 48 months succeeding such first anniversary.
8 Derivative Employee Stock Option (right to buy) 2026-01-15 M D 1,277 $0.00 266,671 D $8.70 · — to 2027-10-04 1,277 Common Stock (F6) Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
9 Derivative Employee Stock Option (right to buy) 2026-01-15 M D 43,166 $0.00 267,948 D $8.70 · — to 2027-10-04 43,166 Common Stock (F6) Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
10 Derivative Employee Stock Option (right to buy) 2026-01-15 M D 809 $0.00 10,668 D $6.78 · — to 2026-10-10 809 Common Stock (F5) Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the the 48 months succeeding such first anniversary.